Non-small cell lung cancer
Clinical research in completely resected non-small cell lung cancer with an emphasis on patients with stage IB, stage II, and stage IIIA disease, particularly where tumour characteristics include PD-L1 expression and EGFR/ALK negativity.
- Adjuvant therapy
- Disease-free survival
- Resected lung cancer
The sponsor’s funded research is centred on post-surgical treatment strategies for lung cancer, with activity spanning multiple countries and collaborating sites in support of oncology-focused clinical development.
